The guidance published on the Medicines and Healthcare products Regulatory Agency (MHRA) website is broadly ... and investigational medicinal products, pharmacovigilance procedures and new IT ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a suite of guidance specifically designed to help medical device manufacturers understand and prepare for the new post ...

The MHRA has released statistics on its pharmacovigilance inspections ... a serious violation of applicable legislation and guidelines. The most prevalent critical finding was reference safety ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer ...

The U.K. Medicines and Health Care Products Regulatory Agency has provided guidance on what does and does not constitute a regulated digital mental health technology, but developers should be aware ...

Nursing Times’ new, open access, learning unit will teach nurses when and how to report suspected adverse drug reactions ...

The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance Certification Program" training has been added to ResearchAndMarkets.com's offering. This training course is designed to give ...

The UK regulatory agency said that future updates may extend the guidance to other personalised therapies, including treatments for rare diseases. June Raine, MHRA’s CEO said: “As an enabling ...